Daily Market Updates: Laurus Labs share price at record high after Q2 results 20⁠⁩26, dividend announcement

Global Markets

Home›Global Markets›North America›Laurus Labs share price at record high after Q2 result…

Laurus Labs share price at record high after Q2 results 20⁠⁩26, dividend announcement - Should you buy pharma stock?

Reported · Written up by our desk · North America

Laurus Labs shares hit a record high after Q2FY27 revenue rose 33% and net profit jumped 126%. The company declared an interim dividend and expanded peptide manufacturing. While brokerages recognized growth prospects, they urged investors to weigh potential against the stock’s sharp rally.

← Newer storyHouthis Claim Fresh Strikes on Saudi Oil Refineries and Aramco Facili…Older story →Trezor warns CryptoBilis buyers to move funds over suspected implant

More like this

Global MarketsSaudi Arabia says Houthis-launched drone destroyed near Mecca, group denies

Global Markets8 companies apply for Hong Kong ride-hailing licences ahead of deadline

Global MarketsNALCO shares: Up 242% in 3 years, is there more rally left in this Navratna PSU? Check Q2 results date, dividend history

Global MarketsChina carries out GJ-21 drone take-off, landing from first Type 076 warship: state media

Global MarketsBP’s third-quarter profit nearly quadruples to $8.5 billion as refining margins surge

Sources

LiveMint MarketsLaurus Labs share price at record high after Q2 results 20⁠⁩26, dividend announcement - Should you buy pharma stock?

Global Markets

Laurus Labs share price at record high after Q2 results 20⁠⁩26, dividend announcement - Should you buy pharma stock?

More like this

Sources

Get the close, explained.